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Abstract
Receptor Tyrosine Kinases (RTKs) are involved in many cellular processes and play a major role in the control of cell fate. For
these reasons, RTK activation is maintained under tight control. Met is an essential RTK that induces proliferation,
differentiation, migration, survival and branching morphogenesis. Deregulation of Met by overexpression, amplification or
lack of effective degradation leads to cancer and metastasis. We have shown that Met relies on CD44v6 for its activation and
for signaling in several cancer cell lines and also in primary cells. In this paper, we show that internalization of Met is
dependent on CD44v6 and the binding of Ezrin to the CD44v6 cytoplasmic domain. Both CD44v6 and Met are co-
internalized upon Hepatocyte Growth Factor induction suggesting that Met-induced signaling from the endosomes relies
on its collaboration with CD44v6 and the link to the cytoskeleton provided by ERM proteins.
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Introduction
Receptor tyrosine kinases (RTKs) orchestrate several cellular
processes such as proliferation, differentiation, migration or
survival. As a consequence the activation process must be kept
under tight control. In physiological conditions, RTK activation is
only transient. Upon ligand stimulation at the cell membrane,
RTKs are internalized via endocytosis and are then either recycled
to the cell membrane or traffic to different endosomal compart-
ments before degradation. The trafficking route ends in the
lysosome, where the degradation process takes place.
It is now well accepted that the internalization process is not
simply a mean to remove cell surface receptors from the
membrane. RTKs such as Epidermal Growth Factor Receptors
(EGF-Rs) accumulate in the endosomes when activated [1]. EGF-
R localized at the endosomal membrane can then meet other
signaling partners and mediate specific cellular responses. Indeed,
Ras can be activated either at the cell surface or at the level of
endosomes whereas activation of phospholipase C (PLC-c) occurs
exclusively at the cell surface [2,3]. Signaling from the endosomes
might simply be a mean to either amplify a specific signaling
pathway or to diversify the cellular responses. Localized signaling
might also help to induce polarized cellular response. Such an
example is shown in the case of the Hepatocyte Growth Factor
(HGF) activation of Rac via the RTK Met. Activation of Rac by
its Guanidine Exchange Factor (GEF), Tiam1 occurs on early
endosomes and depends on Rab5, a small GTPase that is essential
for endocytosis [4]. Recycling of activated Rac to the membrane is
then necessary for actin remodeling.
Met, a major RTK that controls development and tumorigen-
esis gets transiently activated after HGF induction and like most
other RTKs is then internalized via a clathrin-dependent mode
[5]. However, the internalization process and subsequent traffick-
ing is not completely unraveled. Upon activation, Met is
ubiquitinated through the ubiquitin ligase Cbl, a process that
seems not to be required for the internalization step itself as a
mutant of Met in the Cbl binding site, namely Y1003, is still
internalized and accumulates in endosomal membranes where it
promotes sustained Mitogen-Activated Protein Kinase (MAPK)
activation [6]. In the case of other RTKs, such as the Fibroblast
Growth Factor Receptor (FGF-R) [7] and EGF-R [8], mutations
in the major ubiquitination sites also do not affect internalization
(for review, see [9]).
More and more evidence demonstrate that RTKs are not only
activated through ligand binding and that the activation process is
much more complex [10]. One way to increase the panel of
cellular responses consists in collaborating with several partners.
The association of FGF-R with N-cadherin or with E-cadherin is
such an example. In the presence of N-cadherin, FGF-R
internalization is reduced and the accumulation of activated
FGF-R at the cell membrane leads to transformation (reviewed in
[11]). In contrast, both FGF-R and E-cadherin are co-internalized
and transported to the nucleus where cell-cycle progression is
induced.
It is very likely that the various partners recruited by RTKs also
influence the internalization process thereby controlling the
cellular outcome. A prime example of co-receptor control over
RTK trafficking, is given by Vascular Endothelial Growth Factor-
2 (VEGFR-2), the most prominent receptor in angiogenesis.
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Association of VEGFR-2 with its co-receptor neuropilin-1
(reviewed in [12]) promotes recycling through Rab11 vesicles
consequently allowing p38 MAPKinase activation, an essential
pathway for sprouting angiogenesis [13].
Met has been shown to collaborate with several partners such as
integrin b4 [14] or plexins [15]. The best-characterized Met
partners are members of the CD44 family of transmembrane
glycoproteins containing the exon v6 (abbreviated as CD44v6)
(reviewed in [16]). CD44v6 plays a dual role in the Met activation
process. The ectodomain of CD44v6 is required for the activation
step itself, most probably through binding of HGF and presen-
tation to the receptor. In addition, the cytoplasmic domain of
CD44v6 connected to ERM proteins (Ezrin, Radixin, Moesin) and
to the cytoskeleton via the ERM actin-binding domain, is essential
for activation of Ras via its GEF SOS [17,18].
This molecular interaction between CD44v6 and Met is
relevant for several biological processes. Indeed, the entry of the
bacteria Listeria monocytogenes into HeLa cells relies on the interplay
between Met, CD44v6, Ezrin and the cytoskeleton [19]. In vivo,
the angiogenic process [20] and the metastatic propensity of
pancreatic carcinoma cells (Matzke et al., unpublished) also rely
on the association of the Met-CD44v6 signalosome to the
cytoskeleton.
In this paper, using immunofluorescence and biochemical
methods, we show that Met and CD44v6 are co-internalized
and that the cytoplasmic domain of CD44v6 is required for
internalization in addition to the binding of ERM proteins to the
cytoskeleton. Indeed, there is a lack of internalization of Met in the
presence of a cytoplasmic deletion mutant of CD44v6 or an Ezrin
mutant deleted in the actin-binding domain. Blocking of CD44v6
by means of peptides abrogate the internalization process of Met
completely. These data indicate that CD44v6 does not only exert
its function as a co-receptor for Met at the membrane but is also
associated to Met on the trafficking routes where Met is able to
induce specific signaling pathways.
Results and Discussion
1) HGF Leads to Co-internalization of CD44v6 and Met
In order to study the possible role of CD44v6 in Met
internalization we chose HeLa cells in which the internalization
process of Met has extensively been studied [21,22]. In these cells a
high molecular weight band at about 170 kD can be detected by
means of a CD44v6 specific antibody (Figure 1A left). HT29 cells
in which the co-receptor function of CD44v6 for Met was
intensively examined were used as a positive control [17]. The
HepG2 cells that do not express any CD44 isoform [23] were used
as a negative control. The dependency of Met activation towards
CD44v6 has been established in several primary and cancer cells
[17]. Similarly to HT29 cells [24] both the phosphorylation of Met
and Erk could be blocked by means of CD44v6 peptides in HeLa
cells (Figure 1A right and in [19]). Indeed, pre-incubation of HeLa
cells with a CD44v6 5mer (v6pep1) or 14mer (v6pep2) peptide
drastically reduced the phosphorylation of Met and its down-
stream target Erk.
To measure Met internalization we used a modified internal-
ization assay [25]. This assay consists in the labeling of surface
proteins using a biotin harboring a disulfide bond that can be
cleaved off by the reducing agent sodium 2-mercaptoethanesul-
fonic acid (MESNA). HeLa cells were labeled with biotin at 4uC.
At this temperature, the RTKs bind their ligand but do not
internalize and accumulate in clathrin-coated pits [26,27,28]. The
optimal amount of biotin was determined by a titration
experiment (Figure 1B). Cells were lysed and the amount of
labeled proteins was determined by precipitation with a Neu-
trAvidin-coupled resin followed by an SDS-PAGE. 500 mg/ml of
biotin was enough to label both Met and CD44v6 proteins to
saturation under our experimental conditions (Figure 1B upper
part). Upon incubation with MESNA (last lane) no signal could be
detected in the precipitate indicating that the MESNA treatment
removed biotin with 100% efficiency. In Figure 1B lower part, the
cells were labeled with biotin as described above and then induced
with HGF for the indicated time points (lanes 3–7) at 37uC. The
cells were then treated with MESNA three times for 10 minutes at
4uC. Receptors that were internalized were protected from the
MESNA treatment (the cells are not permeable to MESNA) and
could be pulled down from the lysates by means of a NeutrAvidin-
coupled resin. Lane 1 represents a control lane where the cells
were incubated at 4uC in the absence of HGF. The total amount
of biotinylated surface proteins pulled down by NeutrAvidin in the
lysate in the absence of HGF and of MESNA is shown in lane 8.
At 37uC, in the absence of HGF, a basal level of Met
internalization could be observed (lane 2). The internalization of
Met was induced upon incubation with HGF for 10 minutes and
reached a maximum at 30 minutes. After 45 minutes of incubation
with HGF the signal started to decrease and was strongly reduced
at 60 minutes most probably due to Met degradation. Upon
induction with HGF, CD44v6 was also internalized. The time-
course of CD44v6 internalization was similar to the one described
for Met. Indeed, in the case of CD44v6 as well, the maximum of
internalization was observed around 20 to 30 minutes and a
decrease could be seen thereafter. At 60 minutes, degradation of
CD44v6 was also observed as in the case of Met. Unlike CD44v6
and Met, the trafficking of the constitutively recycling transferrin
receptor (TfR) [29] was not affected by incubation with HGF as
shown in Figure 1B lower part. The TfR blot also indicates that
the amount of proteins in each sample was very similar and serves
as an internal control.
In order to confirm that CD44v6 is indeed internalized upon
HGF induction, we used another biochemical method that like the
MESNA experiment also enables to distinguish between internal-
ized versus cell surface proteins (Figure 1C). This technique makes
use of trypsin, an enzyme that can digest proteins such as CD44v6.
If a trypsin digest follows the induction by HGF all cell surface
proteins are cleaved while the internalized proteins are protected
from the extracellular trypsin and remain intact. The cell lysis was
followed by an immunoprecipitation with a CD44v6 antibody. A
basal level of internalization was detected in the absence of HGF
(lane 3). After 10 to 30 minutes (lanes 4–6) of induction with HGF
the internalization of CD44v6 seemed to be maximal similarly to
the MESNA experiment. From 45 minutes on (lanes 7,8), the
signal decreased indicating degradation. Lane 2 shows an
immunoprecipitate of CD44v6 as compared to the unspecific
IgG control immunoprecipitation (lane 1).
Since CD44v6 is required for Met activation, repression of
CD44v6 expression should also have an effect on Met internal-
ization. To test this possibility we performed a MESNA
experiment in HeLa cells transfected with a pool of control
siRNA or a mixture of two siRNAs against CD44v6 (Figure 2A).
Upon downregulation of CD44v6 expression (Figure 2A, right
panel), the internalization of Met was reduced to background level
(Figure 2A, left panel). The internalization of the Transferrin
Receptor (TfR) was not at all affected by inhibition of CD44v6
expression by siRNA. Thus the internalization of Met appears
strictly dependent on CD44v6 most likely due to its role in the
activation of the Met receptor.
Met-induced angiogenesis [20] and Met-induced metastasis of
pancreatic carcinoma cell (Matzke et al, unpublished data) can be
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Figure 1. CD44v6 is internalized upon HGF induction. (A) Left side: Lysates of HT29, HeLa and HepG2 cells were immunoprecipitated with the
CD44v6 antibody (VFF18) and subjected to SDS-PAGE. The blots were probed with the same antibody. Apparent MW is indicated. Right side: starved
HeLa cells were induced for 5 min with HGF (25 ng/ml) and Met and Erk phosphorylation was determined as described in Material and Methods.
Where indicated cells were pre-treated with CD44v6 peptides (v6pep1: 5mer, v6pep2: 14mer) or a control peptide (see Material and Methods). Met
and Erk hybridization was used as loading controls. The experiment was repeated at least three times. (B) Top: The optimal biotin concentration for
efficient biotinylation was determined (50–1000 mg/ml). Serum starved cells were biotinylated for 15 minutes on ice and biotinylated proteins were
pulled down using a NeutrAvidin resin. Both fractions, the pull down (PD) and the supernatant (sup) were subjected to Western Blot analysis using
Met (25H2) and CD44v6 antibodies as indicated. The MESNA treatment (last lane) was tested with the highest concentration of biotin (1 mg/ml).
Below: Serum starved cells were biotinylated (0,5 mg/ml), induced with HGF (50 ng/ml) and treated with MESNA (Material and Methods). After lysis,
internalized (still biotinylated) proteins were pulled down with a NeutrAvidin resin. The fractions were subjected to Western Blot analysis and Met,
CD44v6 and the Transferrin receptor (TfR) were detected with the respective antibodies (Material and Methods). The first sample (lane 1) was kept at
4uC. –M: the cells were not treated with MESNA. (C) HGF-induced internalization of surface proteins detected by the trypsin assay. Serum starved cells
were induced by HGF (25 ng/ml) for the indicated times and then cooled down on ice followed by a treatment with trypsin for 30 minutes (Materials
and Methods). FCS was added to stop the trypsin treatment and the cells were then lysed. CD44v6 was immunoprecipitated and detected by
Western Blot analysis. First lane: immunoprecipitation with IgG.
doi:10.1371/journal.pone.0062357.g001
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inhibited by a CD44v6 specific peptide that interferes with the
CD44v6 co-receptor function. To show that this co-receptor
function of CD44v6 for Met regulates the internalization of Met,
we pre-incubated HeLa cells with a v6 peptide or a control peptide
prior to induction with HGF and followed the internalization
process of Met using confocal microscopy (Figure 2B left). In both
cases (control peptide and v6 peptide treated cells), Met was
located at the membrane in the absence of HGF. In the control
peptide treated cells, Met internalization followed the kinetic
shown in Figure 1B (Figure 2B left). Indeed, strong dotted staining
suggesting endosomal localization could be observed at 30 and 60
minutes of HGF induction. The quantification indicates that most
cells have lost the membrane staining. In stark contrast, Met
stayed at the membrane and almost no internalization was
detected upon pre-incubation of HeLa cells with the CD44v6
peptide (Figure 2B left) that was also shown to abrogate Met
activation in Figures 1A (right side) and Figure 2B below. A similar
experiment was performed with the HT29 cells (Figure 2B right).
In the control peptide treated cells, Met was internalized after
HGF induction. Thus the control peptide has no inhibitory effect.
In contrast, the CD44v6 peptide drastically decreased Met
internalization and Met was detected at the membrane at all time
points. The quantification (Figure 2B below) clearly indicates that
most cells treated with the CD44v6 peptide retained Met at the
membrane. A Western Blot analysis shows the inhibition of Met
activation by the CD44v6 peptides (Figure 2B below).
In order to study whether the cellular distribution pattern of
CD44v6 overlaps with the one observed for Met, we used confocal
microscopy (Figure 3A). HeLa cells were treated with cyclohex-
imide in order to block de novo synthesis of proteins prior to the
induction with HGF. The cells were treated with HGF for one
hour at 4uC to allow binding but not internalization. This
procedure is referred to as a cold start. Receptors were then
allowed to internalize upon temperature increase to 37uC. Directly
after the cold start both CD44v6 and Met were exclusively located
at the plasma membrane. 15 minutes after the 37uC switch, the
membrane staining for both CD44v6 and Met became less
prominent and spots could be detected close to the membrane. 30
minutes post temperature switch, accumulation of Met and
CD44v6 was detected in internal compartments. At 60 minutes,
both proteins could be detected close to the nucleus.
Co-localization was quantified by measuring the Pearson
Coefficient (PC) [30] using the Imaris Software (see Figure 3A).
The mean values of the PC for 6 images are indicated. In all cases
the merged picture and the PC indicate that Met and its co-
receptor CD44v6 are co-localized and traffic together upon HGF
induction.
The intensity profiles were also measured for all time points and
showed a perfect match for the red and the green channels
(Figure. 3B). The width of the peaks at 15, 30 and 60 minutes
corresponds to the size of an endosome (approximately 0.5–1 mm).
To further confirm the possible association between CD44v6
and Met after induction with HGF, endogenous Met was
immunoprecipitated from HeLa cells and immunoblotted with a
CD44v6 antibody at different time points (Figure 3C). The
association between Met and CD44v6 was inducible by HGF as
already described [17] and was maximal after 10 minutes of
induction with HGF at 37uC. Complexes between CD44v6 and
Met could even be detected at 60 minutes. Even after that time the
Met receptor remained activated.
The first intracellular location of RTKs upon uptake is the early
endosome (reviewed in [31]). Rab5 controls the internalization
steps from the membrane to early endosomes and can be used as a
marker of early endosomes [32]. To visualize the trafficking of
CD44v6 and Met to early endosomes we transfected a tagged
wild-type Rab5 construct (mRFP Rab5, red) and a human
CD44v6 construct in HeLa cells (Figure 4A). In this experiment,
cells were submitted to a cold start and fixed immediately (0 min)
or shifted to 37uC for 15 minutes. Cells were stained for CD44v6
(cyan) and for endogenous Met (green). Confocal microscopy
pictures revealed that the three molecules were not co-localized
directly after the cold start (Figure 4A, a and b). However, co-
localization was visible 15 minutes post temperature switch as
indicated by the intensity profiles (Figure 4A,c).
In order to enhance the detection of Rab5 positive endosomes,
we made use of a Rab5 constitutively active GFP construct (Rab5-
Q79L-GFP) that has been used in other studies and behaves
similarly to wild-type Rab5 [13]. Co-transfection of HeLa cells
with this activated Rab5-GFP version and a human CD44v6
construct was performed (Figure. 4B). Met (red) and CD44v6
(cyan) were detected with the respective specific antibodies and
Alexa Fluor-labeled secondary antibodies. The merged picture
showing the distribution of these three proteins and the intensity
profiles revealed that both Met and CD44v6 are present in Rab5
positive endosomes 15 minutes post temperature switch. Directly
after the cold start (0 min), no co-localization was observed and
both Met and CD44v6 were located at the membrane whereas
Rab5 was located on endosomes (Figure 4B, a,b). Colocalization of
Met and endogenous Rab5 (Figure S1) indicate that the wild-type
Rab5 and the constitutively active Rab5 constructs behave like
endogenous Rab5.
Taken together, our data suggest that CD44v6 is recruited to
Met upon HGF induction and traffics together with Met to
internal compartments where at least part of the Met receptor
remains activated. Furthermore, CD44v6 even controls the
internalization process of Met itself.
It was previously shown that Met signaling also emanates from
the endosomal compartment and not exclusively from the plasma
membrane [25,33,34,35]. Indeed, trafficking to endosomes but not
to perinuclear areas seems to be essential for HGF-induced Erk
phosphorylation and is controlled by PKC [35]. In contrast, the
Met-activated STAT3 signaling depends on the perinuclear
localization of Met through a microtubules and PKCa-dependent
process [34]. CD44v6 might stay associated to Met in endosomal
compartments in order to promote signaling from these internal
locations.
Figure 2. CD44v6 controls Met internalization. (A) Left side: HeLa cells were transfected either with a pool of control siRNAs or a mixture of two
different CD44v6 specific siRNAs and starved for 24 hours (Material and Methods). The cells were biotinylated (0,5 mg/ml), induced with HGF (50 ng/
ml) and treated with MESNA. After cell lysis, proteins were pulled down with a NeutrAvidin resin and subjected to Western Blot analysis with Met or
the Transferrin receptor (TfR) antibodies. For the first sample the cells were kept at 4uC. –M: the cells were not treated with MESNA. Right side:
Western Blot analysis of cell lysates of ctrl siRNAs and CD44v6 siRNAs transfected HeLa cells using the CD44v6 and the TfR antibodies. (B) Starved
HeLa cells respectively HT29 cells were incubated with the v6 peptide or a control peptide for 10 minutes at 37uC and then induced with 25 ng/ml of
HGF for the indicated time points. Cells were then either lysed and the lysates were subjected to Western Blot analysis for phospho-Met and Met
(below) or cells were fixed, permeabilized and stained for Met with specific antibodies (red) (above). Nuclei were stained with Dapi and images were
taken with a confocal microscope (Leica SPE) using a 636 objective. The quantification of three independent experiments (n = 40) is shown. The
percentage of cells with Met exclusively located at the plasma membrane was calculated for each time point. Students t test: ***p,0,001.
doi:10.1371/journal.pone.0062357.g002
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2) The CD44v6 Cytoplasmic Domain and Ezrin are
Required for Met Internalization
The cytoplasmic domain of CD44v6 is involved in Met
signaling through its binding to ERM proteins that in turn bind
to the cytoskeleton. This link between the CD44v6 cytoplasmic
domain, ERMs and the cytoskeleton is however not required for
the activation of Met per se. In order to examine the contribution
of the CD44v6 cytoplasmic domain in internalization, we
transfected HeLa cells with a rat CD44 construct containing exon
v6 and deleted from the cytoplasmic domain (CD44v4-7Dcyt) and
performed a MESNA internalization assay (Figure 5A). This
truncated rat protein has been shown to allow Met activation but
not signal transduction to Erk in human cells [18]. Moreover it
allows discriminating between endogenous and transfected CD44
proteins and identifying transfected cells by rat-specific CD44v6
antibodies. In the case of the control vector (lanes 2–5), the pattern
of internalization of Met followed the one that was already shown
in Figure 1B. Indeed, from 10 to 30 minutes of HGF induction,
the amount of Met that was internalized increased drastically as
compared to the sample that was left untreated. In contrast, in the
presence of a CD44v4-7Dcyt protein (lanes 6–9), the internaliza-
tion of Met was reduced to background level.
We then used confocal microscopy to follow Met distribution in
HeLa cells transfected either with a human CD44v6 full-length
construct or a human CD44v6Dcyt construct (Figure 5B). In this
case, the experimental procedure included a cold start. After one
hour of incubation with HGF at 4uC, Met could only be detected
at the membrane in both the CD44v6 full-length and the CD44v6
mutant transfected cells. 15, 30, and 60 minutes post temperature
switch at 37uC, the progressive internalization of Met was
observed in the CD44v6 full-length transfected cells. Dotted
structures were detected close to the membrane at 15 minutes post
temperature switch at 37uC. At 30 and 60 minutes post
temperature switch at 37uC, the punctate structures were closer
to the nucleus. In total contrast, in the mutant CD44v6Dcyt
transfected cells, part of Met seemed to be blocked at the
membrane at all time points and remained co-localized with the
truncated CD44v6 protein. To quantify the effect of the tailless
CD44v6 mutant we counted cells that either had Met exclusively
located at the plasma membrane or where Met was found on the
membrane as well as on endosomes or where Met was exclusively
on endosomes (graph in Figure 5B). The progressive internaliza-
tion in cells transfected with the CD44v6 full-length construct
could be best seen when looking at the percentage of cells with
exclusive endosomal Met. The lack of internalization in cells
transfected with the mutant CD44v6Dcyt is also seen in the graph.
Indeed, the percentage of cells showing an exclusive endosomal
staining is extremely low whereas cells with exclusive Met staining
at the plasma membrane are even found after 60 min.
As we expected from previous experiments regarding the co-
receptor function of CD44 isoforms for Met [17], the experiments
in Figure 5A and B demonstrate that the rat CD44v4-7Dcyt and
the human CD44v6Dcyt both inhibit Met internalization in HeLa
cells. To further confirm this point the experiment of Figure 5B
was repeated using the rat CD44v4-7Dcyt construct instead of the
human CD44v6Dcyt (see Figure S2). In that case as well similar
results were obtained confirming that these two constructs behave
similarly.
The CD44v6 cytoplasmic domain is able to bind to ERM
proteins through a basic stretch of amino acids (for review see
[36]). ERM proteins in turn are able to bind the cytoskeleton
through a C-terminal actin-binding domain. Removal of 29 amino
acids in the C-terminal domain inhibits binding of ERM proteins
to the actin cytoskeleton [37]. To test whether such a network
including the CD44v6 cytoplasmic domain, Ezrin and the
cytoskeleton is as well involved in the internalization process of
Met we analyzed whether a mutation in the actin-binding domain
acts in a dominant negative fashion. In the presence of an Ezrin
protein deleted from its actin-binding domain (EzrinDABD), the
internalization process of Met was reduced in comparison to cells
transfected with the control vector (Figure 5C). After 20 minutes of
HGF induction, the internalization of Met was reduced to 30%.
After 30 minutes, around 50% less internalization took place.
These results suggest that Ezrin through binding to the
cytoskeleton is a major player in the CD44v6 control over Met
internalization. A role of Ezrin and CD44v6 in internalization
might be linked to the movement of Clathrin Coated Vesicles
(CCVs) from the membrane. Actin assembly via activation of N-
WASP or Arp2/3 has been shown to play a role in propulsion of
endocytic vesicles [38]. Several evidences suggest that Ezrin can
indirectly promote de novo actin polymerization in addition to its
F-actin anchoring function. On purified phagosomes Ezrin
induces F-actin assembly by recruiting the N-WASP-Arp2/3
machinery [39]. In the membrane of these phagosomes partners of
Ezrin like the CD44 proteins are also present. It is therefore
possible that CD44 and Ezrin play an important role in
intracellular trafficking at early stages by directly influencing the
CCVs movement. Moreover, Ezrin has already been detected on
endosomes [40].
Another possible role of ERM proteins such as Ezrin in
endocytosis might be the regulation of PIP2 concentrations. The
enrichment and turn over of PIP2 are closely linked to the
assembly and dis-assembly of endocytic vesicles. There is direct
evidence that Ezrin binds PIP2 through its N-terminal domain
[41] and the Ezrin-FERM domain binding to PIP2 might
influence the concentration of PIP2.
Besides the influence of Ezrin on the endocytic machinery, it
might also directly control Met turn over. Indeed, it was recently
reported that Ezrin upon ubiquitination by the ubiquitin ligase
WWP1 is able to control Met stability [42]. The ubiquitination of
Ezrin does not however target it for degradation.
Met itself is also ubiquitinated upon HGF induction. The
ubiquitination of Met seems however not to be involved in
internalization per se but rather in the targeting to the lysosomal
sorting machinery [6]. Indeed, a mutant form of Met that cannot
bind to Cbl and therefore cannot be ubiquitinated is still
Figure 3. Co-localization of Met and CD44v6 in internal compartments after HGF stimulation. (A) Confocal images of endogenous Met
and CD44v6 at different time points after HGF-induction. HeLa cells were serum starved, treated for 2 hours with 50 mM cycloheximide, incubated at
4uC for 1 hour with HGF (25 ng/ml) (cold start) and then shifted to 37uC for the indicated times. After fixation cells were stained for Met (red, AF276)
and CD44v6 (green, VFF18) and nuclei (blue, Draq5) and imaged with the confocal microscope (LSM510) with a 636 objective (Material and
Methods). For each time point, the mean Pearson Coefficient of 4–6 images was calculated using the Imaris software. Scale bar = 15 mm (B) Intensity
profiles of the emission wavelengths of the Met and CD44v6 signals along lines drawn across the plasma membrane or vesicles containing both Met
and CD44v6. The intensity of the respective wavelengths is plotted against the distance in mm. (C) Co-immunoprecipitation of CD44v6 and Met upon
HGF induction. Serum-starved HeLa cells were induced with HGF (50 ng/ml) for the indicated time periods and Met was immunoprecipitated. The
precipitate was subjected to Western Blot analysis and the membrane was blotted for Met, phospho-Met and CD44v6. The experiment was repeated
at least three times.
doi:10.1371/journal.pone.0062357.g003
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internalized but is not able to reach the lysosomes. In agreement
with this observation Met is still ubiquitinated in the absence of
CD44v6 cytoplasmic domain (Figure 6A). In HeLa cells
transfected with the CD44v4-7Dcyt mutant, Met was ubiquiti-
nated after 10, 20 and 30 minutes of induction with HGF similarly
to what happened in the cells transfected with the control vector
(Figure 6A).
However, ubiquitination of proteins required for the first steps
of internalization corresponding to the assembly of the clathrin-
coated pits (CCPs) might be important. Such proteins are AP2,
epsin and Eps15. The latter has been shown to be phosphorylated
and ubiquitinated in response to HGF [43].
3) Signaling Controls Internalization
Since the CD44v6-Met-Ezrin-cytoskeleton complex has already
been shown to be necessary for signaling and more precisely for
the activation of Ras via its GEF SOS [18], the involvement of the
same players in internalization suggests two possibilities: either
signaling is required for internalization or internalization is an
independent event. It has previously been reported that signaling
regulates endocytosis. Indeed, formation of CCPs and CCVs
seems to rely on activation of RTKs signaling at the plasma
membrane (for review, see [44]). Furthermore, the activation of
Rab5, an early mediator of endocytic trafficking [45,46] by the
GEF RIN1 is directly mediated by Ras [47]. Conversely, EGF-
dependent Erk activation was inhibited in HeLa cells transfected
with a K44A dynamin mutant [48] suggesting that internalization
can also control signaling. However, it seems that the activation of
Ras itself might not depend on internalization whereas the step
between MEK and Erk does rely on this process (see review see
[44]). Another example indicating that internalization influences
signaling was recently published in [49]. The Golgi-localized
gamma ear-containing Arf-binding protein (CGA3) was shown to
control Met recycling and thereby sustained Erk activation and
cell migration.
To assess the influence of signaling on the internalization of
Met, we inhibited Ras activation by means of a dominant negative
Ras mutant, HRasN17GFP [50] (Figure 6). In order to prove that
the mutant Ras protein that we used was indeed dominant
negative, we transfected this construct in HeLa cells and measured
Erk phosphorylation (Figure 6B). As expected, the phosphoryla-
tion of Erk was completely blocked confirming that this
HRasN17GFP mutant is indeed dominant negative. In HeLa
cells this dominant negative Ras mutant interfered with Met
internalization (Figure 6C). The quantification (graph in
Figure 6C) gives the percentage of cells where Met was exclusively
located on endosomes. In the Ras mutant transfected cells the
percentage of cells showing an exclusive endosomal staining was
marginal at 30 minutes whereas the control vector transfected cells
mainly showed an exclusive endosomal staining. The influence of
Ras on Met internalization was also measured by means of a
MESNA internalization assay (Figure 6D). In the control vector
transfected HeLa cells, increasing amounts of internalized Met
could be detected after 30 and 60 minutes of HGF induction. In
contrast, Met internalization was drastically reduced in cells
transfected with the Ras dominant negative construct. The TfR
recycling which is not affected by the inhibition of Ras signaling,
serves here as a loading control. To further confirm these results, a
subcellular fractionation was performed on HeLa cells treated with
farnesyl thiosalicylic acid that induce the dislodgement of Ras from
the cell membrane rendering it susceptible to degradation [51].
Pre-incubation of cells with this Ras inhibitor blocked Erk
phosphorylation as shown in Figure 6E left side. In the control
cells, the disappearance of the Met band from the plasma
membrane fraction at 30 and 60 min indicated that internalization
took place. In contrast, the Met signal could be detected at both
time points in the plasma membrane of cells treated with the Ras
inhibitor. The Na+/K+ ATPase is used as a marker for the
membrane fraction [52]. In the endosomal fraction, Met
accumulated with time in the control cells. No Met could be
detected in the endosomal fraction in cells treated with the Ras
inhibitor. EEA1 is used as a marker for endosomes [53].
Taken together, these results suggest that the signaling from the
Met-CD44v6-Ezrin complex influences the internalization of the
Met receptor.
Conclusions
Genetic evidence reveal an interdependence of CD44 and Met
in vivo as mice that are Cd442/2, Met +/2 die at birth and show a
defect in the pre-Bötzinger complex and in the phrenic nerve [54].
The study of the molecular mechanism of action of CD44v6 for
Met demonstrates that CD44v6 participates in Met activation and
signaling (reviewed in [16]). In this paper, an additional function of
CD44v6 for Met in the internalization process strengthens the link
between these two molecules.
Materials and Methods
Antibodies and Other Reagents
The human CD44 exon v6-specific antibody VFF18 was a gift
of Bender (Vienna, Austria). The rat exon v6-specific antibody
1.1ASML has been described [55]. The phospho-Erk (Thr202/
Thr204), the phospho-Met (D26) the Met (25H2) and the
ubiquitin (P4D1) antibodies were purchased from Cell Signaling
Technology (Beverly, UK). The Erk antibody (K-23) was obtained
from Santa Cruz (Heidelberg, Germany), the Transferrin Recep-
tor antibody (ab37632) from Abcam (Cambridge, UK) and the
human Met antibody (AF276) from R&D Systems (Wiesbaden,
Germany). The rabbit IgG and mouse IgG secondary antibodies
were from DAKO (Hamburg, Germany). The EEA1 antibody was
a kind gift from Michael Clague (Liverpool, UK). The antibody
against the Na+/K+ ATPase was purchased from Abcam (Cam-
bridge, UK). The Ras inhibitor (farnesyl thiosalicylic acid) was
purchased from Biomol (Hamburg, Germany). The Rab5
antibody (SPC-168) was bought from StressMarcq. The CD44v6
specific peptides (human 5-mer, human 14-mer) and the control
Figure 4. Colocalization of Met and CD44v6 in Rab5 positive endosomes upon HGF stimulation. (A) HeLa cells were transfected with
mRFP-Rab5 wild type and human CD44v6. After 24 hours the cells were serum starved and treated with 50 mM cycloheximide for 2 hours. Cells were
stimulated with 25 ng/ml HGF for 1hour on ice (cold start) and subsequently shifted to 37uC for the indicated time. Cells were fixed, permeabilized,
and stained for Met (green) and CD44v6 (cyan) with specific antibodies (Materials and Methods). Nuclei were stained with Dapi (blue) and images
were taken with a confocal microscope (Leica SPE) using a 636objective. The last image is an enlargement of the square indicated in the middle
image. Intensity profiles of the respective emission wavelengths of the mRFP-Rab5, Met, and CD44v6 signals were measured along lines drawn across
the plasma membrane (a) or across vesicles (b,c). (B) HeLa cells were transfected with a constitutive active Rab5-GFP construct (Rab5 Q79L-GFP) and a
human CD44v6 construct (see Materials and Methods) and treated as in A. Rab5 Q79L-GFP (green), Met (red), CD44v6 (cyan), Dapi (blue). Intensity
profiles of the respective emission wavelengths of Rab5 Q79L-GFP, Met and CD44v6 are shown on the right side for the indicated endosomes at 15
minutes. Intensity profiles corresponding to the plasma membrane (a) and to an endosome (b) are included for the 0 minute time point (below).
doi:10.1371/journal.pone.0062357.g004
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peptides are described [24]. Lyophilized peptides were dissolved in
PBS 1% BSA to a stock concentration of 1 mg/ml. Recombinant
human HGF (R&D Systems, Wiesbaden, Germany) was activated
with 5% fetal calf serum (FCS; PAA Cölbe, Germany) overnight.
Cell Lines, Cell Culture and Plasmids
The human cervix carcinoma cell line HeLa (American tissue
culture collection, ATCC; Wesel, Germany. Accession No: CCL-
2), the human colon adenocarcinoma cell line HT29, a gift of A.
Zweibaum (Institut National de la Sante et de la Recherche
Medicale, France) and the human hepatoma cells HepG2 (ATCC
Accession No: HB-8065) were grown in Dulbecco’s modified
Eagle’s medium (DMEM; Invitrogen, Karlsruhe, Germany)
supplemented with 10% FCS.
The construct expressing an Ezrin mutant deleted in the actin-
binding domain (EzrinDABD) was a gift from M. Arpin (Institute
Pasteur, Paris, France). The CD44v4-7Dcyt construct has been
described [17]. The HRasS17N-EGFP vector was a gift of Karel
Svoboda (Addgene plasmid #18665) and the EGFP vector was
from Clontech (Takara Bio Europe/Clontech, St.-Germain-en-
Laye, France). The HA-Erk1 construct was a gift from A. Ulrich
(Martinsried, Germany). The constitutively active Rab5-GFP
construct (Rab5a Q79L GFP) has been described [13] and was
kindly provided by Kurt Ballmer-Hofer (PSI, Villingen, Switzer-
land). The human CD44v6 construct corresponds to the CD44
sequence including only the exon v6 in the extracellular domain.
This sequence was cloned into the pEGFP-N2 fusion vector
(Clontech). Since the EGFP tag disturbed the function of the
protein, the expression of EGFP was repressed upon insertion of a
stop-codon behind the CD44v6 sequence. The cloning strategy
can be obtained upon request.
siRNA Inhibition
Cells were transfected with a mixture of two CD44v6-specific
siRNAs: v6-1: 59-AGU AGU ACA ACG GAA GAA ATT-39; v6-
2: 59-GGA UAU CGC CAAACA CCC ATT-39 or a pool of non-
specific control siRNA. The control siRNAs had a 31%,
respectively 47% or 68% GC content: 59-UAA UGU AUU
GGA ACG CAU AUU-39; 59-AGG UAG UGU AAU CGC
CUU GUU-39 and 59-UGC GCU AGG CCU CGG UUG CUU-
39. All siRNAs were obtained from Eurofins MWG GmbH,
Ebersberg, Germany. The transfection was performed using
Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany). Two
rounds of transfection with an interval of 24 h between were
performed. 48 hours after the first transfection the cells were
serum-starved for 24 hours and then subjected to further
treatment.
Activation of RTKs and Erk
Serum-starved cells were induced with the growth factor HGF
(25–50 ng/ml equals 0,3–0,6 nM) at 37uC for the corresponding
time periods. Where indicated, cells were treated with a CD44v6
specific peptide or a control peptide (100 ng/ml) for 10 minutes at
37uC prior to the ligand induction. Cells were washed with ice-
cold phosphate-buffered saline (PBS). To detect activated Erk and
activated Met, cells were lysed in boiling SDS-sample buffer
(125 mM TrisHCl pH 6.8; 4% SDS; 20% Glycerol; 0.01%
bromophenol blue) containing 100 mM dithiothreitol (DTT) and
subjected to Western Blot analysis using antibodies against
phosphorylated Erk or phosphorylated Met. After stripping
(62.5 mM Tris, pH 6.8, 2% SDS, 0.8% DTT; 1 h; 55uC), the
blot was probed with Erk or Met (25H2) antibodies for loading
control. Blots were stained using the enhanced chemiluminescence
system (ECL, Thermo Fisher Scientific, Schwerte, Germany).
Bands in Western Blot analyses were quantified with the program
ImageJ (National Institutes of Health).
Immunoprecipitation
For immunoprecipitation HeLa cells were induced with HGF
(50 ng/ml) for the indicated time periods followed by incubation
in lysis buffer A (60 mM n-octyl -D-glucopyranoside (Sigma-
Aldrich, München, Germany), 0.1% SDS (Sigma-Aldrich,
München, Germany), 10 mM NaF, 1 mM phenylmethylsulfonyl
fluoride, 1 mM Na-orthovanadate, 1 mM aprotinin and 1 mM
leupeptin in HBS) for 30 minutes on ice. Upon centrifugation (12
000 g, 20 min) the cleared lysates were incubated with the
indicated antibodies at 4uC o/n followed by precipitation with
protein A/G agarose beads (Merck, Darmstadt, Germany). The
precipitates were washed three times with lysis buffer A and
subjected to Western Blot analysis.
MESNA Internalization Assay
The experiment was performed as described [25]. HeLa cells
were grown to 70% confluency and serum starved for 24 hours.
Cell surface proteins were biotinylated on ice as described
previously [56]. In brief, cells were washed twice with ice-cold
PBS and subsequently incubated with 0,4 mg/ml sulfosuccinimi-
dyl-2-(biotinamido) ethyl-1,3-dithiopropionate (EZ-LinkSulfo-
NHS-SS-Biotin; Thermo Fisher Scientific, Schwerte, Germany)
in 150 mM Na2B4O7 pH 8 for 15 min on ice followed by three
washing steps with ice-cold serum-free HBS containing 0.1% BSA
and one times HBS containing 0.7 mM CaCl2 and 0.5 mM
MgCl2 (HBS
++) to quench the reaction. Receptor activation and
internalization was induced by shifting the cells to 37uC and
adding pre-warmed serum-free medium containing HGF (50 ng/
ml). The reaction was stopped at 4uC. After one rinse with HBS++
Figure 5. The link between CD44v6 and the cytoskeleton through Ezrin is required for Met internalization. (A) HeLa cells were
transfected with a rat CD44v4-7 construct deleted from the cytoplasmic domain (CD44v4-7Dcyt) or a control vector. The kinetic of Met internalization
upon HGF induction was measured in a MESNA experiment (Material and Methods). In the first sample cells were kept at 4uC. –M refers to a sample
obtained from cells that were not treated with MESNA. The Western Blot analysis was performed with a Met specific antibody and the rat specific
CD44v6 antibody 1.1ASML (Material and Methods). (B) HeLa cells were transfected either with human CD44v6 wild type or with human CD44v6
tailless constructs as indicated. After 24 hours cells were serum starved, treated with 50 mM cycloheximide for 2 hours prior to HGF-induction,
stimulated with 25 ng/ml HGF for 1 hour on ice (cold start) and incubated at 37uC for the indicated time periods. Cells were then fixed, stained, and
imaged using a confocal microscope (Leica SPE) with a 636objective. Met (red), CD44v6 wild type (green), CD44v6 tailless (green), Dapi (blue). Scale
bar = 15 mm. The quantification of three independent experiments (n = 20) is shown. The percentage of transfected cells with Met exclusively located
on endosomes or exclusively at the plasma membrane or on both was calculated for each time point. Values are the means of three independent
experiments. Students t test: *p,0,05 and **p,0,01. (C) HeLa cells were transfected with an Ezrin construct deleted from the actin-binding domain
(EzrinDABD) or a control vector. The cells were serum starved for 24 hours followed by biotinylation (0,5 mg/ml), induced with HGF (50 ng/ml) and
treated with MESNA. Upon cell lysis proteins were pulled down by NeutrAvidin beads. The precipitates were subjected to Western Blot analysis for
Met and CD44v6. For the first sample the cell were kept at 4uC. –M: cells were not treated with MESNA. The experiment was repeated at least three
times.
doi:10.1371/journal.pone.0062357.g005
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Figure 6. HRas signaling is required for HGF-induced Met internalization. (A) HGF-dependent ubiquitination of Met in HeLa cells
transfected with a tailless mutant of CD44. HeLa cells were transfected as indicated with either the rat CD44v4-7Dcyt construct or a control vector as
described in Material and Methods. 24 hours after transfection cells were starved and incubated with HGF (25 ng/ml) at 37uC for the indicated time
periods. The Met immunoprecipitates were loaded for SDS-PAGE and subjected to Western Blot analysis using antibodies against ubiquitin and Met
(Materials and Methods). For quantification, the intensities of the bands corresponding to three independent experiments were used. (B)
Constitutively inactive Ras (HRasS17N) blocks HGF-induced Erk-activation. HeLa cells were co-transfected with HA-Erk and either the constitutively
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the cells were incubated three times for 10 minutes with ice-cold
100 mM sodium 2-mercaptoethanesulfonic acid (MESNA) in
50 mM Tris-HCl pH 8.6, 100 mM NaCl, 1 mM EDTA, and
0.2% BSA. Then the cells were washed twice with HBS++, and
residual MESNA was quenched by incubation with ice-cold
120 mM iodoacetamide in HBS++ (10 min). The cells were
washed two times with ice-cold HBS++ and then incubated with
lysis buffer A (see Immunprecipitation) for 10 minutes followed by
centrifugation (12 000 g, 7 min). The amount of protein in the
supernatant was determined with the BCA kit (Thermo Fisher
Scientific, Schwerte, Germany) and equal amounts were incubated
overnight at 4uC with 40 ml of NeutrAvidin beads (Thermo Fisher
Scientific, Schwerte, Germany). The beads were washed three
times with 1% Triton X-100 (Merck, Darmstadt, Germany) in
HBS and one time with HBS and prepared for SDS-PAGE.
When necessary the cells were transfected with Lipofectamin
(Invitrogen, Karlsruhe, Germany) according to the manufacturer’s
protocol (transfection efficiency around 60%). Cells were then
incubated with medium for 8 h and serum-starved for 24 h before
further processing.
Trypsin Assay
The experiment is a modified version of the one described in
[57]. HeLa cells were grown to 70% confluency and stimulated
with HGF for various time periods. Subsequently, cells were
shifted to 4u, washed twice with PBS and for 7 minutes in ice-cold
20 mM sodium acetate (pH 3,7). After two washing steps with ice-
cold PBS the cells were treated with 0,1% Trypsin (Thermo Fisher
Scientific, Schwerte, Germany) in PBS on ice for 30 minutes
followed by the addition of FCS. The cells were lysed and handled
as described in immunoprecipitation (see above).
Confocal Microscopy
HeLa cells were seeded on 20 mm glass cover slips (Menzel,
Braunschweig, Germany) and serum starved o/n. 2 hours prior to
HGF-induction, 50 mM cycloheximide (Sigma-Aldrich, Tauf-
kirchen) was added. Then the cells were incubated in HGF-
containing (25 ng/ml) serum-free medium for 1 hour on ice to
allow maximal receptor binding (cold start). Subsequently, the cells
were shifted to 37uC for the indicated time periods, chilled on ice,
washed with ice cold PBS, fixed and permeabilized immediately
with methanol (220uC, 10 min) or fixed with 4% paraformalde-
hyde for 15 minutes at RT and permeabilized with 0.3% TritonX-
100 for 3 minutes at RT. The cells were then incubated for 1 hour
in blocking buffer (5% bovine serum albumin, 0.2% Triton X-100,
0.05% Tween 20, PBS) at RT followed by incubation with the
respective primary antibodies in blocking buffer (Met (AF276):
10 mg/ml; VFF18: 10 mg/ml; 1.1ASML: 1 mg/ml) o/n at 4uC.
Cells were then washed three times for 10 minutes with PBS and
incubated with secondary antibodies (for Met: donkey anti goat;
for CD44v6: donkey anti mouse) coupled to the Alexa Fluor 488
(green), 546 (red) or 633 (cyan) label (all from Invitrogen,
Karlsruhe, Germany), Draq5 (Biostatus, Leicestershire, UK,
dilution 1:1 000) or Dapi (dilution 1:10 000) (Life Technologies,
Darmstadt) in blocking buffer for 1 hour at RT. Samples were
mounted with Fluorescence Mounting Medium (Dako, Glostrup,
Denmark) and analyzed with a Zeiss LSM510 or Leica SPE laser
scanning confocal microscope with a 636 objective. Where
indicated cells were transfected with PromoFectin (PromoCell,
Heidelberg, Germany) according to the manufacturer’s protocol
(transfection efficiency around 60%). 24 hours after transfection,
cells were serum starved for 15–18 hours, treated as described
above and analyzed by confocal microscopy.
In the case of blocking experiments, cells were pretreated with
100 ng of CD44v6 peptide (14mer) for 10 minutes at 37uC prior to
induction with HGF (25 ng/ml) in serum-free medium for the
indicated time points. Cells were then washed with ice-cold PBS
and handled as described above.
Ubiquitination Assay
HeLa cells were seeded on 10 cm culture dishes and transfected
with the control vector or CD44v4-7Dcyt constructs with
PromoFectin according to the manufacturers protocol. 24 hours
after transfection, the cells were serum starved o/n and induced
with 25 ng/ml HGF at 37uC for the indicated time points. Then
cells were washed with ice cold PBS and incubated in lysis buffer B
(see Met Degradation) containing 2.5 mg/ml N-ethylmaleimide
(Sigma-Aldrich, Taufkirchen). Cell lysates were cleared by
centrifugation (12 000 g, 10 min) and an aliquot was taken to
determine the transfection efficiency. Met was immunoprecipitat-
ed by incubation with Met antibodies (25H2) o/n at 4uC and then
with Protein A/G agarose beads for 3 hours at 4uC. Beads were
washed four times with lysis buffer B and bound proteins were
separated by SDS-PAGE and subjected to Western Blot analysis.
The Western Blot membrane was then denaturated with 6 M
Guanidin-HCl, 20 mM Tris pH 7,4, 1 mM PMSF and 5 mM 2-
Mercaptoethanol for 30 minutes at 4uC, washed four times with
TBS-T and blocked o/n at 4uC with 5% BSA in TBS-T. The
membrane was incubated with the ubiquitin antibody (1:1 000
dilution) for 1 hour at RT, washed three times for 10 minutes with
TBS-T, incubated with HRP-coupled secondary antibody and
developed with ECL.
Subcellular Fractionation
The membrane/endosome fractionation was described earlier
[58]. Briefly cells were washed once with ice-cold PBS, scraped
and pelleted at 1000 rpm for 5 min. The cell pellet was
resuspended in a homogenization buffer (HB) consisting of
250 mM sucrose in 3 mM imidazole pH 7.4 and protease
inhibitors (10 mg/ml aprotinin, 1 mg/ml pepstatin, 10 mg/ml
inactive Ras (HRasS17N-EGFP) or the control vector. After 24 hours cells were serum starved and induced with HGF (25 ng/ml) for 10 minutes or left
untreated. HA-Erk was immunoprecipitated with a HA-antibody and blotted for phospho-Erk and Erk. (C) Confocal images of endogenous Met after
HGF-induction in HeLa cells transfected with a Ras dominant negative mutant (HRasS17N) or a control vector. HeLa cells were transfected as
indicated either with the HRasS17N-EGFP construct or with a control vector (Material and Methods). After 24 hours cells were serum starved, treated
with 50 mM cycloheximide for 2 hours, then incubated with HGF for 1 hour on ice (cold start) and subsequently shifted to 37uC for the indicated time
period. Cells were then fixed, stained, and imaged using a confocal microscope (Leica SPE) with a 636objective. Met (red), HRasS17N-EGFP (green),
EGFP (green), Dapi (blue). Scale bar = 15 mm. The quantification of three independent experiments (n = 20) is shown. For quantification the
percentage of transfected cells with Met exclusively located on endosomes was calculated. Students t test: **p,0,01. (D) HeLa cells were transfected
with the HRasS17N construct or a control vector. The kinetic of Met internalization upon HGF induction was measured in a MESNA internalization
assay. - M refers to a sample obtained from cells that were not treated with MESNA. The Western Blot analysis was performed with a Met specific
antibody and the TfR antibody. (E) Membrane and endosomal fractions were blotted against Met. Na+/K+ ATPase is used as a control for the
membrane fraction (middle). EEA1 is used as a control for the endosomal fraction (right). Left: Phosphorylation of Erk is blocked in the presence of the
Ras inhibitor (farnesyl thiosalicylic acid).
doi:10.1371/journal.pone.0062357.g006
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leupeptin and 1 mm PMSF) and pelleted again at 2500 rpm for
10 min. The cell pellet was then homogenized in HB supple-
mented with 1 mM EDTA by seven passages through a 24-gauge
needle. Postnuclear supernatant was obtained by centrifugation at
3000 rpm for 10 min. The crude endosomal fraction was then
isolated by adjusting the sucrose concentration of the PNS to
40.6% by adding 62% sucrose (1:1.2, v/v). This fraction was
placed in an SW41 ultracentrifuge tube (Beckman), overlaid with
35% sucrose in HB (4,5 ml) and the tube was filled up with HB.
The samples were centrifuged at 35000 rpm for 1.5 h at 4uC.
Crude endosomal fractions were collected from the interphase
betweeen 35% sucrose and HB and the membrane fraction
between 40.6% and 35% sucrose. Prior to fractionation, the cells
were treated either with a Ras inhibitor (farnesyl thiosalicylic acid)
(5 mM) or DMSO O/N and induced with HGF for 30 and 60
minutes.
Supporting Information
Figure S1 Colocalization of Met (Red) with endogenous
Rab5 (green).
(TIF)
Figure S2 The experiment was performed as described
in Figure 5B. In this case, the cells were transfected with a rat
CD44v4-7Dcyt instead of human CD44v6Dcyt.
(TIF)
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